Paediatric asthma

Show simple item record

dc.contributor.author Green, Robin J.
dc.contributor.author Outhoff, Kim
dc.date.accessioned 2023-02-08T12:21:20Z
dc.date.available 2023-02-08T12:21:20Z
dc.date.issued 2022
dc.description.abstract Childhood asthma has been with us for many years, and prevalence has been increasing. Asthma is the fifth most common killer in our country, and although it may not kill as many people as infectious diseases, the quality of life of an asthmatic may be seriously impaired, leaving a child or adult with compromised lung health that never goes away. The diagnosis of asthma, which is characterised by variable expiratory airflow limitation, is primarily based on recurrent cough and wheeze. Asthma management should be personalised, and longterm asthma management involves assessing, adjusting and reviewing treatment response. Medication should be titrated up or down for individual patient needs. en_US
dc.description.department Pharmacology en_US
dc.description.librarian am2023 en_US
dc.description.uri http://www.sapj.co.za/index.php/sapj en_US
dc.identifier.citation Green, R. & Outhoff, K. 2022, 'Paediatric asthma', SA Pharmaceutical Journal, vol. 89, no. 4, pp. 12-14. en_US
dc.identifier.issn 2221-5875 (print)
dc.identifier.issn 2220-1017 (online)
dc.identifier.uri https://repository.up.ac.za/handle/2263/89345
dc.language.iso en en_US
dc.publisher Medpharm Publications en_US
dc.rights © Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. en_US
dc.subject Paediatric asthma en_US
dc.subject Inhaled corticosteroids en_US
dc.subject Long-acting beta2-agonist (LABA) en_US
dc.subject Short-acting beta2-agonist (SABA) en_US
dc.title Paediatric asthma en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record